ducovest

XLVE:CA:TSX-Mulvihill U.S. Health Care Enh Y ETF (CAD)

ETF | Others |

Last Closing

CAD 7.71

Change

0.00 (0.00)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Currency: CAD

Country : Canada

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-17 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

 CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

 CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

N/A

 CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

N/A

 CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

N/A

 CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

 CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

 CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

N/A

 CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

N/A

 CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

N/A

 CAD 2.68B

ETFs Containing XLVE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -8.21% 4% F 13% F
Dividend Return 6.90% 89% A- 88% B+
Total Return -1.31% 5% F 15% F
Trailing 12 Months  
Capital Gain -2.41% 5% F 14% F
Dividend Return 8.81% 90% A- 90% A-
Total Return 6.41% 14% F 20% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -3.26% 9% A- 14% F
Dividend Return -3.17% 8% B- 11% F
Total Return 0.10% 56% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 5.34% 77% C+ 90% A-
Risk Adjusted Return -59.32% 4% F 4% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.